A Cornell-based startup is advancing a solution that could improve care for the millions of people suffering from urological conditions in the U.S.
CareTech Human, a member of Cornell’s Center for Life Science Ventures, has leveraged $500,000 in pre-seed equity funding to conduct clinical trials of its cutting-edge technology in partnership with several major healthcare institutions, including Weill Cornell Medicine and Cayuga Health, to explore potential applications for patients suffering from overactive bladder and benign prostatic hyperplasia.